×
What we do
SAHMRI Women and KidsAboriginal Health EquityPrecision MedicineLifelong HealthCancerHeart HealthInfection and ImmunityMind and BrainNutrition and MetabolismImagingConsumer and Community EngagementClinical ResearchJoin the Community Interest RegisterSAHMRI Impact
About us
Who we areLeadership and governanceOur boardOur executive teamKey contactsBuilding informationVenue hireOur partnersSAHMRI 2Media partnersOur research advisory committeeAccessibility
Support us
Join our Visionary ProgramBuy a windowMake a gift in memoryMake a gift in celebrationFundraise for usDonate by phone or mailBecome a Corporate ChampionBecome a Founding AmbassadorTrusts and FoundationsSocial impact investingLeave a gift in your willSupport outcomesOur Founding AmbassadorsDonor storiesElle's journeyPrivate Philanthropic FoundationsOur Philanthropic PartnersThe 2018 Wealth and Wellbeing Investment SeminarVideo TestWealth and Wellbeing Seminar Videos and Resources
News
The Library
NewsEventsResourcesJoin a tourReconciliation
SAHMRI. Inspired research, better health.
Research HubResearcher ProfilesStudentsCareers
What we doAbout usSupport usNewsThe Library
×
 
Cancer
Cancer

Cancer

In 2017, more than 130,000 Australians will be diagnosed with cancer.

More than 45,000 Australians will die from cancer.

That's why our cancer researchers are dedicated to finding new and better ways to diagnose and treat cancer.

Our cancer focus

SAHMRI's cancer research focuses on:

  • acute lymphoblastic leukaemia (ALL)
  • chronic myeloid leukaemia (CML)
  • myeloma (blood cancer)
  • prostate cancer
  • colorectal cancer (gastrointestinal cancers including bowel cancer)

 A core focus of the cancer theme are blood cancers - these are a leading cause of childhood death.

Bench to bedside

With a strong focus on translating scientific discoveries into better outcomes for patients, a number of our cancer researchers are also clinicians. Led by Professor Timothy Hughes, our cancer team works across the entire research spectrum, from fundamental genomic discovery, to developmental biology, translational research and the development of innovative clinical trials. Our goal is to make a difference to cancer patients and their outcomes.

A breakthrough for leukaemia patients

Earlier this year, SAHMRI cancer researchers revealed they had developed a test to predict how a patient with chronic myeloid leukaemia will react to standard CML treatment. This test means doctors may not have to wait until a patient fails to respond to treatment before adjusting their treatment strategy. A percentage of CML patients will develop resistance to standard CML treatments, and the ability to identify these patients before drug resistance surfaces gives new hope for their long term outcomes.         

SAHMRI’s Cancer Theme is supported with funding from the Cancer Council’s Beat Cancer Project. 

Get in touch

+61 8 8128 4000
hello@sahmri.com

You can't miss us

North Terrace
Adelaide 5000
South Australia

Postal address

PO Box 11060
Adelaide 5001
South Australia

Connect

Key partners

Founding memberFounding memberFounding memberFounding memberCapital supportMajor funderResearch partnerResearch partner

SAHMRI is located on the traditional lands of the Kaurna people.

The SAHMRI community acknowledges and pays respect to the Kaurna people as the traditional custodians of the Adelaide region. We also acknowledge the deep feelings of attachment and the relationship of the Kaurna people to their country. We pay our respects to the Kaurna peoples' ancestors and the living Kaurna people today.